Foreign object infections

Introduction

FDA data shows that chronic health problems are reduced in most patients who decide to have their breast implants removed (explantation). Nonetheless, breast implant illness (BII) is a controversial illness as many doctors do not believe that breast implants can lead to the development of chronic health problems. Despite presenting data on health outcomes following explantation, the FDA notes that "BII is not recognized as a formal medical diagnosis".

There is currently no test to detect BII and no test that can help predict the outcome of explantation.

FDA data

Outcomes

https://www.fda.gov/medical-devices/breast-implants/medical-device-reports-systemic-symptoms-women-breast-implants

Of the 3,577 MDRs [Medical Device Reporting reports], 1535 (or 43%) reported the patient undergoing device explant at some time following the onset of symptoms. Of these, 1,473 reports provided information sufficient to calculate the time from implantation to explant. The average time to explant was 9 years, with a range of 0- 47 years. Only 290 MDRs provided information related to the status of a woman’s symptoms following explant. Of these, 279 noted improvement and 11 noted either no improvement or worsening of symptoms.

Most common systemic signs or symptoms

Symptom	Percentage of MDRs (N=3,577)
Fatigue	49%
"Brain Fog"	25%
Joint Pain	25%
Anxiety	24%
Hair Loss	21%
Depression	19%
Rash	18%
Autoimmune Diseases (incl. symptoms of autoimmune disease)	18%
Inflammation	18%
Weight Fluctuation	18%

Breast Implant Illness: A Biofilm Hypothesis https://dx.doi.org/10.1097%2FGOX.0000000000002755

Data on breast implant illness

https://www.fda.gov/medical-devices/breast-implants/medical-device-reports-systemic-symptoms-women-breast-implants https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8342259/

Need to add article on ASIA syndrome

siliconosis